Literature DB >> 19853106

Current surgical management of ascending aortic aneurysm in children and young adults.

Masamichi Ono1, Heidi Goerler, Dietmar Boethig, Mechthild Westhoff-Bleck, Thomas Breymann.   

Abstract

BACKGROUND: The low incidence of aortic aneurysm among children and young adults limits information about etiology, surgical indications, procedures of choice, and operative results.
METHODS: From 2003 to 2008, 35 patients aged 7 to 35 years (mean 21) underwent replacement of the ascending aorta for 19 ascending aortic aneurysms and 16 aortic root aneurysms. Underlying diseases included 10 congenital aortic stenoses, 10 bicuspid aortic valves, 8 congenital heart diseases, 6 Marfan syndromes, and 1 aortitis.
RESULTS: Indications for surgery were maximal diameter of 200% of normal for isolated aneurysms, and 160% of normal in case of associated aortic valve dysfunction or symptoms. Operative procedures included 27 ascending aortic replacements with or without aortic valve replacement (including 22 conduits) and 8 valve-sparing operations, performed in 6 patients with Marfan syndrome and 2 with congenital heart diseases. There was 1 in-hospital death. Thirty-four patients survived the operation and are in New York Heart Association functional class II or less at a maximum of 5 years of follow-up. All patients are free from reoperation, but 1 patient had a thromboembolic event. Aortic valve function is good in all 8 patients after the valve-sparing operation.
CONCLUSIONS: Ascending aortic aneurysm in children and young adults was surgically treated with excellent midterm outcome. A diameter of 200% of normal was the indication for surgery; however, in case of associated lesions, smaller diameters should be considered for surgery. Conduit implantation is the gold standard. Valve-sparing operation can be performed in selected patients with encouraging results.

Entities:  

Mesh:

Year:  2009        PMID: 19853106     DOI: 10.1016/j.athoracsur.2009.06.036

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Can the TLR-4-mediated signaling pathway be "a key inflammatory promoter for sporadic TAA"?

Authors:  Giovanni Ruvolo; Calogera Pisano; Giuseppina Candore; Domenico Lio; Cesira Palmeri; Emiliano Maresi; Carmela R Balistreri
Journal:  Mediators Inflamm       Date:  2014-07-10       Impact factor: 4.711

2.  Case Report: Occurrence of Severe Thoracic Aortic Aneurysms (Involving the Ascending, Arch, and Descending Segments) as a Result of Fibulin-4 Deficiency: A Rare Pathology With Successful Management.

Authors:  Paul Thomas; Aparna Venugopalan; Siddharth Narayanan; Thomas Mathew; Lakshmi Parvathi Deepti Cherukuwada; Shilpa Chandran; Jithu Pradeep; Timothy P Fitzgibbons; Vijo George
Journal:  Front Cardiovasc Med       Date:  2021-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.